To hear about similar clinical trials, please enter your email below
Trial Title:
Studying the Clinical Trial Experiences of Patients With Mesothelioma
NCT ID:
NCT05819580
Condition:
Mesothelioma
Conditions: Official terms:
Mesothelioma
Mesothelioma, Malignant
Conditions: Keywords:
mesothelioma
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Medical research participation percentages haven't always been fully representative of a
given demographic.
The goal is to find out which aspects of a clinical study may make it more difficult for
patients to take part or see it through.
The data will be evaluated through different demographic lenses and identify trends that
could help improve the experience of future mesothelioma patients during clinical trials.
Criteria for eligibility:
Study pop:
Mesothelioma patients who are actively considering involvement in an observational
clinical trial, but have not yet completed enrollment and registration.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Must have a medical diagnosis of mesothelioma that has been confirmed by a
physician.
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior
to participation in the study and any related procedures being performed.
- Willing and able to comply with scheduled visits, treatment schedule, laboratory
tests and other requirements of the study.
Exclusion Criteria:
- Pregnant or lactating woman
- Patients with any significant history of non-compliance to medical regimens or with
inability to grant a reliable informed consent.
- Known medical condition that, in the investigator's opinion, would increase the risk
associated with study participation or study drug(s) administration or interfere
with the interpretation of safety results
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
May 2024
Completion date:
May 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05819580
